Abstract
Purpose:
An important cause of avoidable childhood blindness is retinopathy of prematurity (ROP) in countries with high human development index and also in some emerging economies countries. To date, no research have been conducted on analyzing data of ROP prevalence in Babol, and this is the first research performed on ROP in this area.
Methods:
All VLBW babies who referred to Babol ophthalmology center over the seven years, from February 2007 to December 2013 were enrolled in this descriptive cross-sectional research. A team of researchers recorded patients’ information completely in check lists. A single experienced ophthalmologist performed ophthalmologic examination of patients.
Result:
The incidence of ROP of any stage in Babol was determined to be 306 (45%) of all babies enrolled in this study. In present study, key risk factors of ROP were low gestational age, oxygen therapy more than five days and low birth weight.
Conclusion:
The findings of current study demonstrate that the main risk factors of developing ROP in newborns are multiple gestation, low birth weight, oxygen therapy for more than five day. Therefore, the progression of ROP to blindness will be prevented by a high index of suspicion, suitable screening, prompt diagnosis, and early treatment.
Keywords: Birth weight, multiple gestation, prevalence, retinopathy of Prematurity, risk factors, neonates
INTRODUCTION
Retinopathy of prematurity (ROP) affects immature vasculature of premature infants’ eyes. This disease can appear in mild and aggressive forms. No visual sequelae is resulted in the mild form, while aggressive type is along with neovascularization and develop to retinal detachment and blindness [1, 2]. The prevalence of ROP has enhanced because of surviving smaller and younger infants [3].
In countries with high human development index and also in some emerging economies countries, this disease is a main avoidable cause of childhood blindness [4]. ROP is more prevalent in premature babies with low birth weight. Fielder reported the development of ROP in 51% of infants weighing less than 1700 g. Overall, the evidence of ROP is recognized for more than 50% of premature babies weighing less than 1250 gr at birth, and stage 3 ROP is observed in approximately 10% of these babies [5, 6].
On average, 500-700 cases of blindness as a result of ROP are annually reported among American newborns. This can be stated as 30,000 life years of vision in terms of life years of blindness. 2100 newborns will annually be affected by cicatricial sequel such as myopia, blindness, strabismus, and late-onset retinal detachment [7-9]. The thumb rule is that several types of strabismus or refractive error will progress in about 20% of all premature newborns by 3 years of age [10]. For this reason, babies younger than 32 weeks or less than 1500 gr are given follow-up care every 6 months, regardless not or whether ROP is present [5, 11].
Low GA, low BW, sex, oxygen therapy, intra ventricular hemorrhage (IVH), phototherapy and blood transfusion are known as risk factors of this disease [12].
There has been no research until now to analyze data of ROP incidence in north of Iran. Accordingly, this is the first research conducted on ROP prevalence in Babol, which is one of the deprived and developing provinces in north Iran.
MATERIALS AND METHODOLOGY
All very low birth weight (VLBW) babies referred to Babol ophthalmology center over the seven years from February 2007 to December 2013 were entered in this descriptive cross-sectional research. The study obtained ethics approval from the Ethics Committee of Babol University of Medical Sciences. Easy sampling method is used to select the patients in this study. Babies who died before a retinal examination were omitted from the study.
Unlike most international guidelines, newborns with a gestational age less than 36 weeks and 2500g birth weight (BW) were not omitted from the study as there is no screening criteria for ROP in Iran. All information corresponding to sex, gestational age (GA), birth weight, presence of respiratory distress syndrome (RDS), delivery type, oxygen therapy and sepsis were recorded by a team of scientists in a check list. A single experienced ophthalmologist performed ophthalmologic examination of patients.
T-test was applied to perform a comparison between two groups in the terms of the GA, BW, infant's age at examination and oxygen therapy. The comparison of categorical and qualitative variables including sepsis, oxygen therapy, etc. in groups was performed using chi-square test. In order to identify the probability of ROP in study groups, odds ratio (OR) was obtained by using logistic regression statistic tests. SPSS software (Version 21) was used to analysis all data. A P value ˂ 0.05 was considered statistically significant.
RESULT
During the study, 680 of 865 VLBW newborns who were referred were followed up for ROP development. 425 (62.5%) males and 255 (37.5%) females were involved in ROP group. Table 1 shows the average birth weight was 1713.9 ± 416.7 grams and the average gestational age was 31.45 ± 2.21 weeks (7% was 25-28 week, 55% was 29-32 week and 38% was more than 32 week).
Table 1.
Characteristic | No (N %) |
---|---|
Sex Male Female |
425 (62.5%) 255(37.5%) |
Mean birth weight (gr) | 1713.9 ± 416.7 |
Birth weight(groups) 500-1000 1001-1500 1501-2000 >2000 |
48(7%) 197(29%) 292(43%) 143(21%) |
Gestational age 25-28 29-32 >32 |
48(7%) 374(55%) 258(38%) |
Delivery type NVD CS |
201(29.5%) 479(70.5%) |
RDS Yes No |
524(77%) 156(23%) |
Sepsis Yes No |
113(16.7%) 567(83.3%) |
Mean duration of oxygen therapy (day) | 5.21 ± 2.45 |
The overall incidence of ROP in any stage was 306 (45%) among babies who referred to Babol ophthalmology center. Of 306 subjects, 52 (16.99%) subjects were in stage I of ROP, 193 (63.07%) subjects were in stage II and 61 (19.93%) subjects were in stage III or III+.
Table 2 shows the results of logistic regression for all independent variables. There was a significant relationship between GA of 32 weeks or less and ROP (P<0.001).
Table 2.
Characteristic | ROP N(%) |
No ROP N(%) |
OR | Cl | P-Value | |
---|---|---|---|---|---|---|
Sex | Male | 211(69%) | 214(57.2%) | 0.787 | 0.034-1.78 | 0.50 |
Female | 95(31%) | 160(42.8%) | ||||
GA | <32W | 141(46%) | 71(19%) | 2.913 | 1.237-6.862 | 0.01 |
≥32w | 165(54%) | 303(81%) | ||||
Oxygen therapy >5 day |
Yes | 267(87.2%) | 245(65.5%) | 1.793 | 0.629-5.110 | 0/32 |
No | 39(12.8%) | 129(34.5%) | ||||
RDS | Yes | 141(46%) | 183(49%) | 0.853 | 0.380-1.913 | 0/87 |
No | 165(54%) | 191(51%) | ||||
Sepsis | Yes | 65(21%) | 41(10%) | 2.889 | 1.093-7.633 | 0.04 |
No | 241(79%) | 333(90%) | ||||
Birth weight(gram) | <1500gr | 133(43.5%) | 83(22.1%) | 3.512 | 1.415-8.719 | 0.007 |
1500gr≤ | 173(56.5%) | 291(77.9%) | ||||
ROP stage | I II III |
52(16.99%) 193(63.07%) 61(19.93%) |
0(0%) 0(0%) 0(0%) |
2.713 | 1.123-7.766 | 0.001 |
Furthermore, it was observed that babies with BW of less than 1500 g are 3.5 times more at risk for ROP compared to babies with 1500g or more. A significant relationship was observe between sepsis and ROP (P<0.001).
In ROP group, the mean oxygen therapy was 7.12 ± 4.32 day and this value in healthy group was 3.23 ± 2.18 day. Thus, there is no significant relationship between oxygen therapy with ROP (P>0.05).
DISCUSSION
In current study, the incidence of ROP in any stage, from February 2007 to December 2013 was 306 (45%) among babies referred to Babol ophthalmology center. ROP is considered as an important avoidable cause of blindness in children in countries with high human development index and also in some emerging economies countries [4]. One country is different from another one in terms of the ROP prevalence depending on birth weights, gestational age, and risk factors. Three epidemics have been reported since 1942 after recognizing ROP: The first epidemic was during 1940-1945 when oxygen therapy was recognized as the main reason; the next one occurred between 1960-1970 due to developing neonatal care in industrial countries that enhanced survival of babies with ELBW; and the last one from 1980 until now because of increasing the survival of preterm babies with gestational age more than 32 weeks and a birth weight greater than 1500 grams using the newborn care accessible in developing countries with limited resources [13, 14].
The ROP rate in the current study was 45 %, which was higher as compared to available literature in this context including 32.4 % in Pakistan [15], 29.5 % in Tehran [16], 29.2 % in Singapore [18], 29 % in Kerman (southern Iran) [19], and 10.45 % in the United States [17]. Moreover, Sabzehi et al. [20] reported that the ROP incidence in Tehran was 17.4 % in 3 years study. In another study conducted by Mousavi et al. [21], the prevalence of ROP in Farabi hospital of Tehran was 34.4% in 4 years. Furthermore, the ROP prevalence was reported 37.1% by Mutlu et al. [22].
The outstanding risk factors for ROP have been addressed in this study; our findings are in a good accordance with those obtained from other studies. it was found that multiple gestations is an independent risk factor in progression of ROP in studied subjects as well as the results of Blumenfield’s study, although there was no difference between the ROP severity for children of a multiple gestation and infants of singletons [23]. In a research conducted by Riazi-Esfahani et al. [24], there was observed no significant difference in the rate or severity of ROP between babies of a multiple gestation and singletons unlike the study of Dos Santos Motta et al. [25] on 26 cases in which multiple gestation was considered as a risk factor for progression and severity of ROP.
It was found that oxygen therapy duration is an independent risk factor for ROP that was > 40 days, > 30 days, > seven days and > five days in the studied of Niwald et al. [26], Pinheiro et al. [27], Hakeem et al. [28] and present study, respectively.
CONCLUSION
The findings of current study demonstrate that the main risk factors for infants to develop ROP are multiple gestation, low birth weight, oxygen therapy for more than five days. Therefore, the progressing ROP to blindness will be prevented with a high index of suspicion, apposite screening, rapid diagnosis, and early treatment.
CONFLICT OF INTEREST
The authors confirm that this article content has no conflict of interest.
ACKNOWLEDGEMENTS
Declared none.
REFERENCES
- 1.American Academy of Pediatrics (Section on Ophthalmology) Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2001;108(3):809–811. doi: 10.1542/peds.108.3.809. [DOI] [PubMed] [Google Scholar]
- 2.American Academy of Pediatrics (Section on Ophthalmology); American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006;117(2):572–576. doi: 10.1542/peds.2005-2749. [DOI] [PubMed] [Google Scholar]
- 3.Phelps D. Retinopathy of prematurity. In: Fanaroff A., Martin R., editors. Neonatal-Perinatal medicine. Philadelphia, PA: Saunders Elsevier; 2011. pp. 1764–70. [Google Scholar]
- 4.Filho F.J.B., Eckert G.U., Procianoy L., Barros C.K., Procianoy R.S. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond.) 2009;23(1):25–30. doi: 10.1038/sj.eye.6702924. [DOI] [PubMed] [Google Scholar]
- 5.Chen Y., Li X.X., Yin H., Gilbert C., Liang J.H., Jiang Y.R., Zhao M.W., Beijing ROP Survey Group Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. Br. J. Ophthalmol. 2008;92(3):326–330. doi: 10.1136/bjo.2007.131813. [DOI] [PubMed] [Google Scholar]
- 6.Binkhathlan A.A., Almahmoud L.A., Saleh M.J., Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br. J. Ophthalmol. 2008;92(2):167–169. doi: 10.1136/bjo.2007.126508. [DOI] [PubMed] [Google Scholar]
- 7.Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum. Dev. 2008;84(2):77–82. doi: 10.1016/j.earlhumdev.2007.11.009. [DOI] [PubMed] [Google Scholar]
- 8.Gergely K., Gerinec A. Retinopathy of prematurity--epidemics, incidence, prevalence, blindness. Bratisl. Lek Listy (Tlacene Vyd) 2010;111(9):514–517. [PubMed] [Google Scholar]
- 9.Ahmadpour-Kacho M., Motlagh A.J., Rasoulinejad S.A., Jahangir T., Bijani A., Pasha Y.Z. Correlation between hyperglycemia and retinopathy of prematurity. Pediatr. Int. 2014;56(5):726–730. doi: 10.1111/ped.12371. [DOI] [PubMed] [Google Scholar]
- 10.Good W.V., Hardy R.J., Dobson V., Palmer E.A., Phelps D.L., Quintos M., Tung B., Early Treatment for Retinopathy of Prematurity Cooperative Group The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005;116(1):15–23. doi: 10.1542/peds.2004-1413. [DOI] [PubMed] [Google Scholar]
- 11.Fielder A.R., Reynolds J.D. Retinopathy of prematurity: clinical aspects. Semin. Neonatol. 2001;6(6):461–475. doi: 10.1053/siny.2001.0091. [DOI] [PubMed] [Google Scholar]
- 12.Gandhi B., Rich W., Finer N. Time to achieve stable pulse oximetry values in VLBW infants in the delivery room. Resuscitation. 2013;84(7):970–973. doi: 10.1016/j.resuscitation.2012.12.007. [DOI] [PubMed] [Google Scholar]
- 13.Bell M.J., Ternberg J.L., Feigin R.D., Keating J.P., Marshall R., Barton L., Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 1978;187(1):1–7. doi: 10.1097/00000658-197801000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Clemett R., Darlow B. Results of screening low-birth-weight infants for retinopathy of prematurity. Curr. Opin. Ophthalmol. 1999;10(3):155–163. doi: 10.1097/00055735-199906000-00001. [DOI] [PubMed] [Google Scholar]
- 15.Taqui A.M., Syed R., Chaudhry T.A., Ahmad K., Salat M.S. Retinopathy of prematurity: frequency and risk factors in a tertiary care hospital in Karachi, Pakistan. J. Pak. Med. Assoc. 2008;58(4):186–190. [PubMed] [Google Scholar]
- 16.Karkhaneh R., Mousavi S.Z., Riazi-Esfahani M., Ebrahimzadeh S.A., Roohipoor R., Kadivar M., Ghalichi L., Mohammadi S.F., Mansouri M.R. Incidence and risk factors of retinopathy of prematurity in a tertiary eye hospital in Tehran. Br. J. Ophthalmol. 2008;92(11):1446–1449. doi: 10.1136/bjo.2008.145136. [DOI] [PubMed] [Google Scholar]
- 17.Lad E.M., Nguyen T.C., Morton J.M., Moshfeghi D.M. Retinopathy of prematurity in the United States. Br. J. Ophthalmol. 2008;92(3):320–325. doi: 10.1136/bjo.2007.126201. [DOI] [PubMed] [Google Scholar]
- 18.Shah V.A., Yeo C.L., Ling Y.L., Ho L.Y. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann. Acad. Med. Singapore. 2005;34(2):169–178. [PubMed] [Google Scholar]
- 19.Ghaseminejad A., Niknafs P. Distribution of retinopathy of prematurity and its risk factors. Iran. J. Pediatr. 2011;21(2):209–214. [PMC free article] [PubMed] [Google Scholar]
- 20.Sabzehei M.K., Afjeh S.A., Farahani D.A., Shamshiri A.R., Esmaili F. Retinopathy of prematurity: incidence, risk factors, and outcome. Arch. Iran Med. 2013;16(9):507–512. [PubMed] [Google Scholar]
- 21.Mousavi S.Z., Esfahani R.M., Roohipoor R., et al. Characteristics of advanced stages of retinopathy of prematurity. Indian J. Ophthalmol. 2010;22(2):19–24. [Google Scholar]
- 22.Mutlu F.M., Altinsoy H.I., Mumcuoglu T., Kerimoglu H., Kiliç S., Kul M., Sarici S.U., Alpay F. Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey: frequency, outcomes, and risk factor analysis. J. Pediatr. Ophthalmol. Strabismus. 2008;45(5):291–298. doi: 10.3928/01913913-20080901-12. [DOI] [PubMed] [Google Scholar]
- 23.Blumenfeld L.C., Siatkowski R.M., Johnson R.A., Feuer W.J., Flynn J.T. Retinopathy of prematurity in multiple-gestation pregnancies. Am. J. Ophthalmol. 1998;125(2):197–203. doi: 10.1016/S0002-9394(99)80092-0. [DOI] [PubMed] [Google Scholar]
- 24.Riazi-Esfahani M., Alizadeh Y., Karkhaneh R., Mansouri M.R., Kadivar M., Nili Ahmadabadi M., Nayeri F. Retinopathy of prematurity: single versus multiple-birth pregnancies. J. Ophthalmic Vis. Res. 2008;3(1):47–51. [PMC free article] [PubMed] [Google Scholar]
- 25.Dos Motta S.M.M., Filho F.J.B., Coblentz J., Fiorot C.A. Multiple pregnancies and its relationship with the development of retinopathy of prematurity (ROP). Clin. Ophthalmol. 2011;5:1783–1787. doi: 10.2147/OPTH.S25431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Niwald A. Risk factors of 3rd stage retinopathy of prematurity progression. Klin. Oczna. 2000;102(6):449–453. [PubMed] [Google Scholar]
- 27.Pinheiro A.M., Silva W.A., Bessa C.G., Cunha H.M., Ferreira M.A., Gomes A.H. Incidence and risk factors of retinopathy of prematurity in University Hospital Onofre Lopes, Natal (RN)-Brazil. Arq. Bras. Oftalmol. 2009;72(4):451–456. doi: 10.1590/S0004-27492009000400005. [DOI] [PubMed] [Google Scholar]
- 28.Hakeem A.H., Mohamed G.B., Othman M.F. Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr. J Ophthalmol. 2012;19(3):289–294. doi: 10.4103/0974-9233.97927. [DOI] [PMC free article] [PubMed] [Google Scholar]